AZN vs VTRS
As of Sep 20, 2026, Astrazeneca (AZN) scores 5.0/10 and Viatris (VTRS) 5.0/10 on AlphaStocks' five-model composite, the same score. AZN trades 14% below its model fair value; VTRS trades 15% below its model fair value.
AZN
ASTRAZENECA PLC
5.0
Consider Buy
$166.29
VTRS
Viatris Inc
5.0
Consider Buy
$16.93
AZN vs VTRS: Which is the Better Investment?
ASTRAZENECA PLC (AZN) scores 5.0/10 while Viatris Inc (VTRS) scores 5.0/10 on AlphaStocks' composite model. Both stocks share the same composite score. Viatris Inc trades further below its estimated fair value.
This comparison is algorithmically generated and is not financial advice.
| Metric | AZN | VTRS |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 5.0/10 | 5.0/10 |
| Rating | Consider Buy | Consider Buy |
| Price | $166.29 | $16.93 |
| P/E Ratio | 25.4 | — |
| ROE | 21.9% | 114.4%▲ |
| Market Cap | $260B | $20B |
| Fair Value | $192.63 | $20.00 |
| Dividend Yield | 1.9% | — |
| Sector Rank | #111 of 168▲ | #115 of 168 |
| Model Verdicts | ||
| Piotroski | Strong▲ | Neutral |
| Buffett | Strong▲ | Caution |
| Graham | Caution▲ | Limited Data |
| Lynch | Neutral | Attractive▲ |
| Greenblatt | Neutral▲ | Limited Data |
Related comparisons
AZN vs VTRS: Which Stock Scores Higher?
ASTRAZENECA PLC (AZN) and Viatris Inc (VTRS) are both in the Health Care sector. Both stocks are closely matched with composite scores of 5.0/10.
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer